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Absence of Goniodysgenesis in
Patients with Chromosome
13Q Microdeletion-Related
Microcoria
Congenital microcoria (MCOR; MIM156600) is a rare develop-
mental ocular disorder of the anterior segment (AS) that is caused
by submicroscopic deletions on the long arm of human chromo-
some 13 (13q32.1).1 All deletions reported thus far encompass 2
genes, TGDS and GPR180.1,2 The ocular phenotype was not
reproducible in the gpr180e/e or gpr180þ/e mouse model.1
Iridocorneal angle dysgenesis usually is described in patients
with MCOR.1,3,4 Histopathologic studies have revealed thick
juxtacanalicular connective tissue consisting of trabecular cell
layers embedded in the extracellular matrix of ﬁbrous and amor-
phous substances similar to patients with goniodysgenetic glau-
coma.3 Onset of MCOR-associated glaucoma ranges from
childhood, as early as 6 years of age,2 to late-onset in the third to
fourth decade of life, caused by goniodysgenesis as shown by
histopathologic analysis.3 Herein we present 3 patients with a large
and unreported 13q32.1 deletion associated with MCOR without
goniodysgenesis and glaucoma to demonstrate the phenotype
variability.
This was a retrospective single-center chart review of 3 affected
patients of a nonconsanguineous family. All patients gave written
consent to analyze their data. The research adhered to the tenets of
the Declaration of Helsinki. The Cantonal Ethics Committee of
Zurich conﬁrmed the exempt status of this study. All patients
underwent a detailed eye examination. Anterior segment
spectral-domain OCT (Spectralis; Heidelberg Engineering GmbH,
Heidelberg, Germany) was performed in the index patient and her
brother.
Genetic analyses of the 3 patients and the unaffected father of
the index patient were performed stepwise as follows from Clinical
Laboratory Improvement Amendment (CLIA)-approved labora-
tories: (1) whole-exome sequencing, (2) copy number analysis
using the CytoScan HD Array from Affymetrix (ATLAS Biolabs
GmbH, Berlin, Germany), (3) long-range polymerase chain reac-
tion (PCR) ampliﬁcation of the deletion breakpoint fragments, (4)
deletion breakpoint mapping by conventional PCR, and (5) Sanger
sequencing of the junction fragments.
The index patient, her brother, and her mother were examined at
the ages of 27 years, 36 years, and 59 years, respectively. All 3
patients reported having small pupils since childhood. Myopic
corrections were prescribed to all patients from early childhood
onward. No other ocular or extraocular malformations or systemic
diseases were diagnosed. Family history revealed a similar condi-
tion in the maternal grandfather of the index patient and in 2 of his
siblings, although no consanguinity was known.
Ocular Morphologic Features and Function
All patients demonstrated reduced visual acuity ranging from 0.6 to
0.16 (decimal Snellen). Myopia-associated retinal changes with
choroidal neovascularization treated with photodynamic therapy in
the right eye and atrophic macular changes in the left eye led to
severe vision loss in patient III:2 in addition to possible pre-existing
amblyopia. No corneal or lenticular abnormalities were visible.
Phacoemulsiﬁcation cataract extraction with intraocular lens im-
plantation was performed in patient IV:2 in the right eye at 36 years
of age and in his mother (III:2) in both eyes at 51 years of age. Iris
appearance was characteristically abnormal in all patients: pupil
diameter of less than 2 mm (except in the eyes after cataract surgery),
minimal iris pigmentation, stromal thinning with corresponding
transillumination, featureless iris with poorly developed collarettes
and crypts, deep iris root, and increased visibility of the iris vascu-
larization. The iridocorneal angle was minimally pigmented and open
(Shaffer 3 to 4). The iris root was positioned just below Schwalbe’s
line. Hence, the ciliary body band was visible in its superior part
(Fig 1). Pupils responded minimally to topically administrated
tropicamide eye drops. Intraocular pressure was less than 15
mmHg in all patients. Anterior segment OCT conﬁrmed the very
thin iris stroma beginning in the mid periphery and extending
toward the angle with continuously preserved posterior pigmented
epithelium without signs of goniodysgenesis. High-resolution spec-
tral domain AS OCT and swept-source AS OCT provide valuable
information of the AS, especially the anterior chamber angle. It is
even possible to visualize Schlemm’s canal. Hence, it provides in-
formation on the angle width, location of iris insertion in comparison
to Schlemm’s canal and scleral spur, and angle anatomy, for
example, angle recession. However, the depth of penetration of OCT
is limited. Therefore, it usually is not possible to visualize structures
behind the iris, for example, iris cysts. For these entities, ultrasound
biomicroscopy would be the diagnostic tool of choice (Fig 1). The
optic nerve showed a tilted conﬁguration in all 3 patients with a
small cup-to-disc ratio of 0.2 in patients IV:1 and IV:2, but was
not measurable because of tilting in patient III:2. The size of the optic
nerve measured by the SD OCT measurement tool varied from small
(1.5 mm in diameter in patient IV:2), to horizontal-oval shape (VI:1:
right eye, 2.161.77 mm; left eye, 2.061.69 mm, horizontal 
vertical, respectively), to upright-oval shape (III:2: right eye,
1.281.98 mm; left eye, 1.52.18 mm, horizontal  vertical,
respectively; Fig S1, available at www.ophthalmologyglaucoma.org).
Visual ﬁeld results are available in 1 patient (III:2) that show central
to paracentral scotoma corresponding to maculopathy and a temporal
scotoma corresponding to the myopic fundus changes in the left eye
more than in the right eye (Fig S1).
Genetic Analyses
On whole-exome sequencing data analysis, no pathogenic variant
was found in literature-selected genes, which have been associated
with different forms ofmicrocoria. Copy number analysis usingCopy
Number estimation by aMixtureOf PoissonS (cn.MOPS)5 suggested
a heterozygous deletion of the neighboring genes TGDS and
GPR180. Consequently, a copy number analysis on CytoScan HD
data using ChAS version 3.1 was performed for the index patient
and the affected mother, which conﬁrmed the presence of an 80- to
84-kb deletion on the long arm of chromosome 13 (13q32.1)
including both genes. Primers were designed to amplify the break-
point regions by multiplex PCR. The PCR products were run on a
Bioanalyzer DNA 7500, which revealed a third product of
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approximately 4.2 kb in length in all affected patients that was not
present in the unaffected father or in an unrelated control. The 4.2-kb
fragment was sequenced on aMiSeq using the Nextera XT library kit
(Illumina). A STAR aligner6 was used to split the junction reads and
visualize the exact breakpoints. Sanger sequencing conﬁrmed the 82
656-bp deletion (Chr13(GRCh37):g.95209609_95292265del; Fig
S2, available at www.ophthalmologyglaucoma.org). The deletion
was not present in 278 in-house ethnically matched controls
without any apparent eye condition.
A temporal sequence of differentiation events is characteristic
for human iris development. The dilator pupillae muscle devel-
opment occurs at approximately 6 months of gestation, which is
later than the sphincter pupillae muscle growth. The dilator
pupillae muscle extends radially to the pupil from the anterior or
pigmented epithelial layer of the iris. Interruption of the anterior
and stromal iris development will be associated with dilator
muscle hypotrophy and small pupils as present in patients with
MCOR. Variable phenotype severity may be associated with the
reported deletion. All deletions described to date include the 2
genes TGDS and GPR180, and it is not yet clear whether a
deletion of both genes is associated with the MCOR phenotype or
if the deletion or mutation of one of them would be sufﬁcient to
elicit the phenotype. Interestingly, a 2-generation family with
unique heterozygous GPR180 nonsense mutations associated with
iridocorneal angle dysgenesis but normal pupillary response and
absence of iris transillumination was described.1 The cases
presented herein add to the phenotypic spectrum associated with
TGDS or GPR180 gene deletions, ranging from isolated
goniodysgenesis, to microcoria with iris hypoplasia but without
goniodysgenesis,7 to the full MCOR phenotype with glaucoma.
A goniodysgenetic chamber angle is the result of abnormal
migration or differentiation of the neural crest-derived mesen-
chymal cells. However, only some patients with goniodysgenetic
chamber angles will demonstrate glaucoma, which is referred to as
dysgenetic or developmental glaucoma and which occurs earlier in
life than open-angle glaucoma. Goniodysgenesis is a fetal mal-
development or underdevelopment of the iridocorneal angle,
resulting in an immature angle.8 Typically gonioscopic ﬁndings
are: (1) high location of the iris root at the level of Schwalbe’s
line, the trabecular meshwork, or the scleral spur9; (2) abnormal
remnants that cover the angle recess and the trabecular
meshwork; (3) abnormalities in the appearance of the trabecular
meshwork (for example, in color or width); (4) the absence of
the angle recess and prominence or displacement of Schwalbe’s
line; (5) loops of vessels from the major arterial circle; (6)
numerous iris processes; and (7) a narrow or irregular ciliary
body band.
Iris hypoplasia or rupture (corectopia), ectopic pupils (polycoria),
and tissue strands or adhesions between the iris and the cornea
(peripheral anterior synechiae) are AS ﬁndings and can be associated
with goniodysgenesis, but it is known that goniodysgenesis cannot
explain the occurrence of glaucoma per se. Hence, the described
goniodysgenesis in MCOR patients with anterior insertion of the iris
root alone does not necessarily lead to the development of glaucoma.
Patients with MCOR may demonstrate late-onset developmental
glaucoma.10 All reported deletions to date are different from each
other, which suggests independent events. The region seems to be
prone to nonrecurrent microhomology-mediated deletions. The
deletion event reported herein might have been mediated by the Alu
repeat elements that overlap with the breakpoint regions.1 In fact, the
proximal and distal regions share a 15-bp long identical nucleotide
sequence that is part of some Alu repeat subfamilies. Interestingly,
this homologous sequence also is present in proximity of the
breakpoints of the smallest deletion reported,1 and it recurs 11 times
(its reverse complement 8 times) in the region where deletions have
been described.
In conclusion, the rare chromosome 13q-related microcoria can
be associated with a phenotypic spectrum of variable severity. Mild
MCOR features require regular, lifelong screening for glaucoma-
tous changes despite the underlying pathogenesis being unknown
Figure 1. A, Pedigree of 3 affected patients. B, Anterior segment phenotype in iris photography of the 3 affected patients demonstrating reduced iris
pigmentation and iris stroma thinning, with visible transillumination on indirect illumination. The iridocorneal angle in all 3 patients is open, low pig-
mented, and without signs of goniodysgenesis. Horizontal anterior spectral-domain OCT scans through the pupillary level of patients IV:1 and IV:2 (left eye
shown only) revealing a preserved posterior iris pigment, but thinned iris stroma.
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to date. Deletion size does not seem to correlate with phenotypic
manifestations.
CHRISTINA GERTH-KAHLERT, MD1,*
JORDI MAGGI, MSC2,*
MARC TÖTEBERG-HARMS, MD1
AMIT TIWARI, PHD2
BIRGIT BUDDE, PHD3
PETER NÜRNBERG, PHD3,4,5
SAMUEL KOLLER, PHD2
WOLFGANG BERGER, PHD2,6,7
1Department of Ophthalmology, University Hospital Zurich, Zurich,
Switzerland; 2Institute of Medical Molecular Genetics, University of
Zurich, Schlieren, Switzerland; 3Cologne Center for Genomics,
University of Cologne, Cologne, Germany; 4Center for Molecular
Medicine Cologne, University of Cologne, Cologne, Germany;
5Cologne Excellence Cluster on Cellular Stress Responses in Aging-
Associated Diseases, University of Cologne, Cologne, Germany;
6Zurich Center for Integrative Human Physiology, University of Zurich,
Zurich, Switzerland; 7Neuroscience Center Zurich, University and ETH
Zurich, Zurich, Switzerland
*Both authors contributed equally as ﬁrst authors.
Financial Disclosure(s): The author(s) have made the following dis-
closure(s): M.T.-H.: Consultant e Novartis/Alcon, Allergan, Aerie
Pharmaceutics; Financial support e Iridex; Lecturer e Novartis/Alcon,
Santen, Iridex, Allergan.
A.T.: Employee e Sophia Genetics SA.
HUMAN SUBJECTS: Human subjects were included in this study. The
Cantonal Ethics Committee of Zurich conﬁrmed the exempt status of
this work. All participants provided informed consent. The research
adhered to the tenets of the Declaration of Helsinki.
No animal subjects were included in this study.
Author Contributions:
Conception and design: Gerth-Kahlert, Maggi, Tiwari, Koller, Berger
Analysis and interpretation: Gerth-Kahlert, Maggi, Töteberg-Harms,
Tiwari, Budde, Nürnberg, Koller, Berger
Data collection: Gerth-Kahlert, Maggi, Töteberg-Harms, Tiwari, Budde,
Nürnberg, Koller, Berger
Obtained funding: None
Overall responsibility: Gerth-Kahlert, Maggi, Töteberg-Harms, Koller,
Berger
Correspondence:
Christina Gerth-Kahlert, MD, Department of Ophthalmology, Univer-
sity Hospital Zurich, Frauenklinikstrasse 24, CH 8091 Zurich,
Switzerland. E-mail: christina.gerth-kahlert@usz.ch.
References
1. Fares-Taie L, Gerber S, Tawara A, et al. Submicroscopic de-
letions at 13q32.1 cause congenital microcoria. Am J Hum
Genet. 2015;96(4):631e639.
2. Sergouniotis PI, Ellingford JM, O’Sullivan J, et al. Genome
sequencing identiﬁes a large deletion at 13q32.1 as the cause
of microcoria and childhood-onset glaucoma. Acta Oph-
thalmol. 2017;95(3):e249ee250.
3. Tawara A, Inomata H. Familial cases of congenital microcoria
associated with late onset congenital glaucoma and gonio-
dysgenesis. Japanese J Ophthalmol. 1983;27(1):63e72.
4. Toulemont PJ, UrvoyM,CoscasG, et al. Association of congenital
microcoria withmyopia and glaucoma. A study of 23 patients with
congenital microcoria. Ophthalmology. 1995;102(2):193e198.
5. Klambauer G, Schwarzbauer K, Mayr A, et al. cn.MOPS:
mixture of Poissons for discovering copy number variations in
next-generation sequencing data with a low false discovery
rate. Nucleic Acids Res. 2012;40(9):e69.
6. Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast uni-
versal RNA-seq aligner. Bioinformatics. 2013;29(1):15e21.
7. Ramirez-Miranda A, Paulin-Huerta JM, Chavez-Mondragon E,
et al. Ultrabiomicroscopic-histopathologic correlations in in-
dividuals with autosomal dominant congenital microcoria: three-
generation family report. Case Rep Ophthalmol. 2011;2(2):
160e165.
8. Tawara A, Inomata H, Tsukamoto S. Ciliary body band width
as an indicator of goniodysgenesis. Am J Ophthalmol.
1996;122(6):790e800.
9. Gupta V, Srivastava RM, Rao A, et al. Clinical correlates to
the goniodysgenesis among juvenile-onset primary open-angle
glaucoma patients. Graefes Arch Clin Exp Ophthalmol.
2013;251(6):1571e1576.
10. Tawara A, Itou K, Kubota T, et al. Congenital microcoria
associated with late-onset developmental glaucoma.
J Glaucoma. 2005;14(5):409e413.
Report
147
